Skip to main content
Top of the Page
ABT

Reports and Publications

Australia's Regenerative Medicines Investment Database 2021

In Australia, the signs point to increasing interest amongst investors in investing in regenerative medicine (RM) with $394.1m invested in 2020, compared with just $184.7m in 2019, a 113% increase in funding.

Click here


Back to Top